WEISS ASSET MANAGEMENT LP reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/28/2026ACC: 0001357550-26-000033
10% Owner
Since Sep 2022
-7.46M
Net shares
Net seller
$126.77M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
7.46M disposed
Non-Derivative Transactions1
Ordinary Share $0.00001 Par Value
Indirect
Shares
−7.46M
Price / share
$17.00
Trade value
$126.77M
% of position
New position
9/23/2026
7.46M→0.00
Total
Net shares
−7.46M
Net value
-$126.77M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Share $0.00001 Par Value Indirect | 9/23/2026 | J · J | −7.46M | $17.00 | $126.77M | New position | 7.46M | 0.00 |
| Total | −7.46M | -$126.77M | ||||||
Derivative Transactions0
No derivative transactions reported